Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OPRK1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MEX3C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DGKE | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ATP5F1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NUTM2D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FOXP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PKIA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | KIAA1211 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SIDT2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |